Breakingviews: Pharma M&A day

Breakingviews columnists review Abbott Labs' seemingly value-destructive $25 bln deal to buy St. Jude Medical and AbbVie's blowout price for a Silicon Valley cancer drug developer.

Read more

Breakingviews: Apple bruises

The tech giant suffered a rare drop in revenue and an unprecedented fall in iPhone sales. Rob Cyran and Reynolds Holding discuss how Apple Pay and other services could turn things around.

Read more

Breakingviews: Merger advice M&A

Perella Weinberg and Tudor Pickering Holt could be joining forces. Breakingviews editors discuss the logic of these boutique dealmakers dealing with each other.

Read more

Breakingviews: Tribune's new barracks

Antony Currie and Jennifer Saba explain why shareholders of the company that publishes the L.A. Times and Chicago's lead newspaper should accept Gannett's $815 mln offer.

Read more

Breakingviews: Obama in London

Breakingviews editors wonder if the U.S. president's support for Britain staying in the EU will change minds, when gut feelings similar to those driving Donald Trump's fans are at work.

Read more

Breakingviews: Trolling Verizon

Jen Saba and Richard Beales look at Verizon's earnings and T-Mobile US's cheeky assertion that its larger rival is having "a midlife crisis" with its recent millennial-oriented acquisitions

Read more

Breakingviews: Google vs. EU

European trustbusters' allegation that Google abused its market dominance in smartphones is a losing battle for both sides, but one worth fighting. Rob Cyran and Jeffrey Goldfarb explain.

Read more